185 related articles for article (PubMed ID: 37204665)
1. Organoid models derived from patients with malignant phyllodes tumor of the breast.
Chu X; Wu M; Yang J; Fu Y; Wang X; Wang H; Xiao Y; Chen D; He J
Breast Cancer Res Treat; 2023 Jul; 200(2):193-201. PubMed ID: 37204665
[TBL] [Abstract][Full Text] [Related]
2. Successful Treatment of a Locally Recurrent and Metastatic Malignant Phyllodes Tumor with Accelerated Radiotherapy and Nab-Paclitaxel, Cisplatin, and Liposomal Doxorubicin Chemotherapy.
Koukourakis IM; Zygogianni A; Kouloulias V; Koukourakis MI
Chemotherapy; 2021; 66(3):82-86. PubMed ID: 34233328
[TBL] [Abstract][Full Text] [Related]
3. In vivo chemosensitivity of human malignant cystosarcoma phyllodes xenografts.
Ueyama Y; Abe Y; Ohnishi Y; Sawa N; Hatanaka H; Handa A; Tokuda Y; Yamazaki H; Kijima H; Tamaoki N; Nakamura M
Oncol Rep; 2000; 7(2):257-60. PubMed ID: 10671667
[TBL] [Abstract][Full Text] [Related]
4. Phyllodes tumors of the breast.
Khan SA; Badve S
Curr Treat Options Oncol; 2001 Apr; 2(2):139-47. PubMed ID: 12057132
[TBL] [Abstract][Full Text] [Related]
5. An approach to malignant mammary phyllodes tumors detection.
Ilić I; Randelović P; Ilić R; Katić V; Milentijević M; Velicković L; Krstić M
Vojnosanit Pregl; 2009 Apr; 66(4):277-82. PubMed ID: 19441158
[TBL] [Abstract][Full Text] [Related]
6. Organoid Culture of Isolated Cells from Patient-derived Tissues with Colorectal Cancer.
Xie BY; Wu AW
Chin Med J (Engl); 2016 Oct; 129(20):2469-2475. PubMed ID: 27748340
[TBL] [Abstract][Full Text] [Related]
7. Unusual aggressive breast cancer: metastatic malignant phyllodes tumor.
Singer A; Tresley J; Velazquez-Vega J; Yepes M
J Radiol Case Rep; 2013 Feb; 7(2):24-37. PubMed ID: 23705037
[TBL] [Abstract][Full Text] [Related]
8. Organoid Cultures Derived From Patients With Papillary Thyroid Cancer.
Chen D; Tan Y; Li Z; Li W; Yu L; Chen W; Liu Y; Liu L; Guo L; Huang W; Zhao Y
J Clin Endocrinol Metab; 2021 Apr; 106(5):1410-1426. PubMed ID: 33524147
[TBL] [Abstract][Full Text] [Related]
9. Retrospective study of malignant phyllodes tumors of the breast: Younger age, prior fibroadenoma surgery, malignant heterologous elements and surgical margins may predict recurrence.
Li Y; Song Y; Lang R; Shi L; Gao S; Liu H; Wang P
Breast; 2021 Jun; 57():62-70. PubMed ID: 33774460
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant chemotherapy with doxorubicin and dacarbazine has no effect in recurrence-free survival of malignant phyllodes tumors of the breast.
Morales-Vásquez F; Gonzalez-Angulo AM; Broglio K; Lopez-Basave HN; Gallardo D; Hortobagyi GN; De La Garza JG
Breast J; 2007; 13(6):551-6. PubMed ID: 17983394
[TBL] [Abstract][Full Text] [Related]
11. Head and neck cancer organoids established by modification of the CTOS method can be used to predict in vivo drug sensitivity.
Tanaka N; Osman AA; Takahashi Y; Lindemann A; Patel AA; Zhao M; Takahashi H; Myers JN
Oral Oncol; 2018 Dec; 87():49-57. PubMed ID: 30527243
[TBL] [Abstract][Full Text] [Related]
12. Breast sarcomas and malignant phyllodes tumours: comparison of clinicopathological features, treatment strategies, prognostic factors and outcomes.
Lim SZ; Selvarajan S; Thike AA; Nasir ND; Tan BK; Ong KW; Tan PH
Breast Cancer Res Treat; 2016 Sep; 159(2):229-44. PubMed ID: 27541020
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer organoids from malignant pleural effusion-derived tumor cells as an individualized medicine platform.
Pan B; Zhao D; Liu Y; Li N; Song C; Li N; Li X; Zhao Z
In Vitro Cell Dev Biol Anim; 2021 May; 57(5):510-518. PubMed ID: 33950403
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for recurrence and death after primary surgical treatment of malignant phyllodes tumors.
Asoglu O; Ugurlu MM; Blanchard K; Grant CS; Reynolds C; Cha SS; Donohue JH
Ann Surg Oncol; 2004 Nov; 11(11):1011-7. PubMed ID: 15525831
[TBL] [Abstract][Full Text] [Related]
15. Malignant phyllodes tumors display mesenchymal stem cell features and aldehyde dehydrogenase/disialoganglioside identify their tumor stem cells.
Lin JJ; Huang CS; Yu J; Liao GS; Lien HC; Hung JT; Lin RJ; Chou FP; Yeh KT; Yu AL
Breast Cancer Res; 2014 Mar; 16(2):R29. PubMed ID: 24670249
[TBL] [Abstract][Full Text] [Related]
16. Apatinib treatment is effective for metastatic malignant phyllodes tumors of the breast: a case report.
Wang X; Xie L; Hu W; Yan J; Qian X; Zhu L
BMC Womens Health; 2021 May; 21(1):218. PubMed ID: 34022875
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive genomic profiling of malignant phyllodes tumors of the breast.
Nozad S; Sheehan CE; Gay LM; Elvin JA; Vergilio JA; Suh J; Ramkissoon S; Schrock AB; Hirshfield KM; Ali N; Ganesan S; Ali SM; Miller VA; Stephens PJ; Ross JS; Chung JH
Breast Cancer Res Treat; 2017 Apr; 162(3):597-602. PubMed ID: 28210881
[TBL] [Abstract][Full Text] [Related]
18. Outcome and predictive factors of local recurrence and distant metastases following primary surgical treatment of high-grade malignant phyllodes tumours of the breast.
Kapiris I; Nasiri N; A'Hern R; Healy V; Gui GP
Eur J Surg Oncol; 2001 Dec; 27(8):723-30. PubMed ID: 11735168
[TBL] [Abstract][Full Text] [Related]
19. Ifosfamide is an active drug for chemotherapy of metastatic cystosarcoma phyllodes.
Hawkins RE; Schofield JB; Wiltshaw E; Fisher C; McKinna JA
Cancer; 1992 May; 69(9):2271-5. PubMed ID: 1314127
[TBL] [Abstract][Full Text] [Related]
20. An integrative approach for exploring the nature of fibroepithelial neoplasms.
Yun J; Heo W; Lee ES; Na D; Kang W; Kang J; Chae J; Lee D; Lee W; Hwang J; Yoo TK; Hong BS; Son HY; Noh DY; Lee C; Moon HG; Kim JI
Br J Cancer; 2023 Feb; 128(4):626-637. PubMed ID: 36522480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
